Literature DB >> 2906555

Behavioural responses to the selective D1-dopamine receptor agonist R-SK&F 38393 and the selective D2-agonist RU 24213 in young compared with aged rats.

A G Molloy1, J L Waddington.   

Abstract

1. In aged male Sprague-Dawley rats (22 months) with a selective loss of D2- but not of D1-dopamine receptors, stereotyped behaviour induced by 0.5 mg kg-1 apomorphine was increased and prolonged in comparison with young (4 month) counterparts. This suggested a pharmacokinetic effect rather than a pharmacodynamic change. 2. The syndrome of non-stereotyped behavioural responses to the selective D1-agonist R-SK&F 38393, 1.25-20.0 mg kg-1, was unchanged in aged vs young animals, but the topography of individual behaviours constituting this overall syndrome was altered with aging. 3. Neither the overall syndrome of low intensity stereotyped behaviour nor the topography of individual behaviours induced by the selective D2-agonist RU 24213, 1.25-20.0 mg kg-1, were altered in aged vs young animals. 4. Loss of D2- but not D1-receptors with aging was therefore found to be associated with no change in responsivity to a D2-receptor agonist. The decreased intense grooming and increased vacuous chewing responses to the D1-agonist with aging parallel the previously demonstrated effects of selective D2-antagonists on these D1-stimulated behaviours. 5. It is suggested that age-related decline in D2-receptor activity may have greater functional consequences in relation to D1-:D2-interactions than in simply influencing responsivity to a D2-agonist. Such interactive effects should be taken into account when considering the pathophysiology and treatment of age-related extrapyramidal movement disorders.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2906555      PMCID: PMC1854188          DOI: 10.1111/j.1476-5381.1988.tb11651.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

Review 1.  Enantiomeric analogues of SCH 23390 as new probes for behavioral interactions between D1 and D2 dopaminergic function.

Authors:  J L Waddington; A G Molloy; K M O'Boyle; M Mashurano
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

2.  Effect of aging on striatal dopamine receptor subtypes in Wistar rats.

Authors:  J M Henry; C R Filburn; J A Joseph; G S Roth
Journal:  Neurobiol Aging       Date:  1986 Sep-Oct       Impact factor: 4.673

3.  Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.

Authors:  J Arnt; J Hyttel; J Perregaard
Journal:  Eur J Pharmacol       Date:  1987-01-13       Impact factor: 4.432

4.  Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393.

Authors:  M Mashurano; J L Waddington
Journal:  Neuropharmacology       Date:  1986-08       Impact factor: 5.250

5.  Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors.

Authors:  A R Braun; T N Chase
Journal:  Eur J Pharmacol       Date:  1986-11-19       Impact factor: 4.432

Review 6.  Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems.

Authors:  J L Waddington
Journal:  Biochem Pharmacol       Date:  1986-11-01       Impact factor: 5.858

7.  Changes in the mechanisms of hormone and neurotransmitter action during aging: current status of the role of receptor and post-receptor alterations. A review.

Authors:  G S Roth; G D Hess
Journal:  Mech Ageing Dev       Date:  1982-11       Impact factor: 5.432

8.  Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study.

Authors:  J H Carlson; D A Bergstrom; J R Walters
Journal:  Brain Res       Date:  1987-01-06       Impact factor: 3.252

9.  Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists.

Authors:  A G Molloy; K M O'Boyle; M T Pugh; J L Waddington
Journal:  Pharmacol Biochem Behav       Date:  1986-07       Impact factor: 3.533

10.  A re-evaluation of changes in rat striatal D-2 dopamine receptors during development and aging.

Authors:  K M O'Boyle; J L Waddington
Journal:  Neurobiol Aging       Date:  1986 Jul-Aug       Impact factor: 4.673

View more
  7 in total

1.  Age-related changes in human D1 dopamine receptors measured by positron emission tomography.

Authors:  T Suhara; H Fukuda; O Inoue; T Itoh; K Suzuki; T Yamasaki; Y Tateno
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 2.  Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.

Authors:  A R Braun; M Laruelle; M M Mouradian
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Analysis of the effects of intra-accumbens SKF-38393 and LY-171555 upon the behavioural satiety sequence.

Authors:  G D Phillips; S R Howes; R B Whitelaw; T W Robbins; B J Everitt
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

Review 4.  Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment.

Authors:  Richard M Kostrzewa; Nuo-Yu Huang; John P Kostrzewa; Przemyslaw Nowak; Ryszard Brus
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

5.  Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.

Authors:  S R Wachtel; R J Brooderson; F J White
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats.

Authors:  A Plech; R Brus; J H Kalbfleisch; R M Kostrzewa
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

Review 7.  Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.

Authors:  Jamie A Burns; Danielle S Kroll; Dana E Feldman; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.